EYPT stock forecast
Our latest prediction for EyePoint Pharmaceuticals, Inc.'s stock price was made on the Aug. 24, 2020 when the stock price was at 0.61$.
In the short term (2weeks), EYPT's stock price should outperform the market by 5.19%. During that period the price should oscillate between -11.32% and +24.44%.
In the medium term (3months), EYPT's stock price should outperform the market by 24.30%. During that period the price should oscillate between -45.51% and +63.20%.Get email alerts
Create a solid portfolio with EYPT
About EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
At the moment the company generates 23M USD in revenues.
On its last earning announcement, the company reported a loss of -0.46$ per share.
The book value per share is 0.16$
Three months stock forecastAug. 24, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|